Literature DB >> 34084059

Ameliorative Role of Diallyl Disulfide Against Glycerol-induced Nephrotoxicity in Rats.

Ashwani Kumar Sharma1, Anmoldeep Kaur1, Japneet Kaur1, Gurpreet Kaur1, Apporva Chawla1, Mannan Khanna1, Harmanpreet Kaur1, Harnoor Kaur2, Tajpreet Kaur2, Amrit Pal Singh1.   

Abstract

INTRODUCTION: This study investigated the role of diallyl disulfide (DADS) against glycerol-induced nephrotoxicity in rats. Moreover, the role of peroxisome proliferator activated receptor-γ (PPAR-γ) in DADS-mediated renoprotection has been explored.
MATERIALS AND METHODS: Male Wistar albino rats were challenged with glycerol (50% w/v, 8 mL/kg intramuscular) to induce nephrotoxicity. Kidney injury was quantified by measuring serum creatinine, creatinine clearance, urea, potassium, fractional excretion of sodium, and microproteinuria in rats. Renal oxidative stress was measured in terms of thiobarbituric acid reactive substances, superoxide anion generation, and reduced glutathione levels. Hematoxylin-eosin (H&E) and periodic acid Schiff staining of renal samples was done to show histological changes. Glycerol-induced muscle damage was quantified by assaying creatine kinase (CK) levels in rat serum.
RESULTS: Administration of glycerol resulted in muscle damage as reflected by significant rise in CK levels in rats. Glycerol intoxication led kidney damage was reflected by significant change in renal biochemical parameters, renal oxidative stress and histological changes in rat kidneys. Administration of DADS attenuated glycerol-induced renal damage. Notably, pretreatment with bisphenol A diglycidyl ether, a PPAR-γ antagonist, abolished DADS renoprotection in rats.
CONCLUSION: We conclude that DADS affords protection against glycerol-induced renal damage in rats. Moreover, PPAR-γ plays a key role in DADS-mediated renoprotective effect. Copyright:
© 2020 Journal of Pharmacy and Bioallied Sciences.

Entities:  

Keywords:  Diallyl disulfide; PPAR-γ; glycerol; kidney; rhabdomyolysis

Year:  2020        PMID: 34084059      PMCID: PMC8142911          DOI: 10.4103/jpbs.JPBS_177_20

Source DB:  PubMed          Journal:  J Pharm Bioallied Sci        ISSN: 0975-7406


INTRODUCTION

Rhabdomyolysis is a clinical syndrome characterized by skeletal muscle injury, which causes release of cell components such as myoglobin, electrolytes, and various sarcoplasmic enzymes into systemic circulation.[1] These released cellular contents result in renal vasoconstriction, tubular cast formation, and apoptosis, which eventually causes nephrotoxicity.[2] Clinical development of rhabdomyolysis is attributed to various reasons such as crush syndrome, exhaustive exercise, medications, infections, and toxins. Rhabdomyolysis is estimated to account for 5%–15% of total cases of acute kidney injury (AKI). In preclinical studies, rhabdomyolysis-induced nephrotoxicity is produced by intramuscular injection of glycerol, which imitates the human condition of rhabdomyolysis-induced AKI.[3] Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors of nuclear receptor superfamily having three subtypes: PPAR-α, PPAR-β/δ, and PPAR-γ. They play a vital role in energy metabolism; however, they differ in the range of their activity.[4] More recently, the anti-inflammatory functions of PPAR-γ have received much attention, as its agonists have been shown to exert a broad range of protective effects in several animal models of neurological, cardiovascular, and renal diseases.[5] The PPAR-γ agonists such as rosiglitazone and pioglitazone have protective effects against ischemia reperfusion-induced kidney injury, diabetic-hypertensive-nephropathy, experimental glomerulonephritis, and drug-induced renal injury.[6] Diallyl disulfide (DADS) is natural molecule obtained from garlic and possesses anti-inflammatory and antioxidant activities.[789] DADS has been reported as active ingredient responsible for anti-atherosclerotic effect of garlic oil. Most recently, DADS has been reported to protect against acetaminophen and cisplatin-induced kidney injury in rodents, which primarily owes to its antioxidant and anti-inflammatory properties.[1011] Few citations available in literature suggest a crosstalk between DADS and PPAR-γ. However, the relevance of this crosstalk has never been addressed in models of kidney injury.[1213] This study investigated the role of DADS against glycerol-induced nephrotoxicity in rats. Moreover, potential involvement of PPAR-γ in DADS-mediated renoprotection is explored.

MATERIALS AND METHODS

The animal experiments were carried out in accordance with the guidelines framed by Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment, Forests and Climate Change, Government of India. Institutional Animal Ethics Committee (IAEC) of Guru Nanak Dev University, Amritsar approved the animal protocol (226/CPCSEA/2018/12). Male Wistar albino rats (20–22 weeks) weighing 270–300 g were used in this study. Animals were housed in the Central Animal Facility of Guru Nanak Dev University, Amritsar (Registration No. 226/PO/Re/ S/2000/CPCSEA). Animal had free access to standard chow and water.

Experimental protocol

Forty-six animals were randomly divided into six groups. DADS was dissolved in corn oil and pioglitazone was suspended in 0.5% carboxymethyl cellulose. Bisphenol A diglycidyl ether (BADGE) was dissolved in minimum volume of ethanol and final volume was made with distilled water. Group 1 (control, n = 6): no treatment was given to rats. Group 2 (glycerol 50% w/v, 8 mL/kg, n = 8): glycerol was administered intramuscularly in hind limbs of rats to induce nephrotoxicity. After 24 h of glycerol administration, the rats were sacrificed. Group 3 (glycerol + DADS, 50 mg/kg, n = 8): DADS (50 mg/kg, p.o.) was administered for five consecutive days. On fifth day, glycerol was administered after 1 h of DADS treatment and animals were sacrificed after 24 h. Group 4 (Glycerol + DADS, 100 mg/kg, n = 8): DADS (100 mg/kg, p.o.) was given for five consecutive days followed by treatment mentioned in group III. Group 5 (glycerol + pioglitazone, n = 8): pioglitazone (10 mg/kg, p.o.) was administered for five consecutive days. On fifth day, glycerol was given after 1 h of pioglitazone treatment and animals were sacrificed after 24 h. Group 6 (glycerol + DADS + BADGE, n = 8): BADGE (30 mg/kg, i.p.) was administered 1 h prior to DADS followed by treatment as mentioned in Group 3. After respective treatments and glycerol administration, animals were placed in individual metabolic cages for a 24-h urine collection. After 24 h, the rats were anaesthetized. Blood samples were collected using retro-orbital puncture and rats were sacrificed by cervical dislocation. Serum isolated from blood was used for estimation of creatinine, urea, sodium and potassium level. Moreover, the creatinine, sodium, and protein content in urine were estimated. Rat kidneys were removed and washed with 1.17% potassium chloride (KCl) solution. A part of renal tissue was preserved in neutral buffered formalin (NBF) for histological studies. Small portion of renal tissue was used for estimation of superoxide anion generation (SAG) and the rest of tissue was minced and homogenized in 1.17% KCl solution (10% w/v) using teflon homogenizer. Contents were centrifuged at 800× g for 10min to remove the cellular debris and re-centrifuged at 11,000× g for 20min. The clear supernatant was used to estimate lipid peroxides and reduced glutathione (GSH) levels in kidneys. In addition, creatine kinase (CK) was assayed in serum as markers of muscle injury.

Quantification of kidney injury in rats

Estimation of creatinine in serum and urine samples was done by using commercially available kits. Creatinine clearance (CrCl) was calculated by using the following formula: (CrCl = urine creatinine × urine volume / serum creatinine × 24 × 60 × animal wt). CrCl was expressed as milliliter per minute per kilogram of rat weight. Estimation of urea in serum samples was done by using commercially available kits and expressed as milligram per milliliter of serum. Potassium level was estimated in the serum sample using kit and expressed as millimoles per liter of serum. Sodium level was estimated in the serum and urine samples colorimetrically. Fractional excretion of sodium (FeNa) was calculated by using formula: (FeNa = [serum sodium × urine creatinine/urine sodium × serum creatinine] × 100). Results of FeNa were expressed as percentage change in the values. Microproteins were estimated in urine samples by using colorimetric kit. Microproteinuria was calculated using formula: [microproteinuria = microproteins × urine collected in 24 h]. Results were expressed as milligram per day.

Quantification of oxidative stress in rat kidneys

Quantitative measurement of TBARS, an index of lipid peroxidation in renal tissues, was performed according to method previously described Brar et al.[14] SAG in the renal tissue was evaluated using method described by Brar et al.[14] Results were expressed as reduced NBT picomoles per minute per milligram of tissue. GSH content of renal tissue was estimated and expressed as micromoles of reduced glutathione per milligram of protein Arora et al.[15]

Histological studies

Renal tissues preserved in 10% NBF were dehydrated in graded concentrations of ethanol, immersed in xylene and then embedded in paraffin. Sections of 4 µm thickness were stained with hematoxylin–eosin (H&E) and periodic acid Schiff (PAS) stains using standardized protocols.[6] Sections stained with H&E stain were evaluated under microscope (Nikon Eclipse 80i) at ×100 magnification for gross histopathological changes and neutrophil accumulation, whereas tubular brush border damage was evaluated by PAS staining.[1617]

Drugs and chemicals

DADS was purchased from Tokyo Chemical Industry, Chennai, India. BADGE was procured from Sigma Aldrich, Bangalore, India. Pioglitazone was a kind gift from Panacea Biotec, India. Glycerol was purchased from SRL, Mumbai, India. All other reagents used in the study were of analytical grade.

Statistical analysis

Results were expressed as mean ± standard error of mean (SEM). Data obtained from various groups were statistically analyzed using one-way analysis of variance followed by Tukey–Kramer post hoc test. P < 0.05 was considered to be statistically significant.

RESULTS

Mortality of two animals was observed in glycerol-treated rats. One animal died in glycerol + DADS (50 mg/kg) and glycerol + DADS + BADGE group. Data of surviving animals have been presented in the Results section.

Effect of diallyl disulfide on renal parameters

A significant increase in serum creatinine, urea, electrolytes (potassium and FeNa), and microproteinuria was observed in glycerol-treated rats as compared to control group. Glycerol administration resulted in a marked reduction in CrCl in rats. DADS (50 and 100 mg/kg) produced renoprotective effect in rats. Pioglitazone treatment attenuated glycerol-induced changes in renal parameters in rats. Prior administration of BADGE abolished DADS-induced kidney protection in rats [Figure 1].
Figure 1

Effect of DADS on renal parameters in rats. Values are expressed as mean ± SEM. aP < 0.05 vs. Control; bP < 0.05 vs. Gly; cP < 0.05 vs. Gly + DADS 50

Effect of DADS on renal parameters in rats. Values are expressed as mean ± SEM. aP < 0.05 vs. Control; bP < 0.05 vs. Gly; cP < 0.05 vs. Gly + DADS 50

Effect of diallyl disulfide on renal oxidative stress in rats

A significant increase in renal oxidative stress (measured as increased TBARS, SAG, and decreased GSH levels) was observed in glycerol-treated rats as compared to control group DADS significantly attenuated oxidative stress in rats, which was comparable to pioglitazone-mediated antioxidant effect. Pretreatment with BADGE abolished DADS-mediated antioxidant effect of in rats [Figure 2].
Figure 2

Effect of DADS on renal oxidative stress and creatine kinase level in rats. Values are expressed as mean ± SEM. aP < 0.05 vs. Control; bP < 0.05 vs. Gly; cP < 0.05 vs. Gly + DADS 50

Effect of DADS on renal oxidative stress and creatine kinase level in rats. Values are expressed as mean ± SEM. aP < 0.05 vs. Control; bP < 0.05 vs. Gly; cP < 0.05 vs. Gly + DADS 50

Histological evaluation of the effect of diallyl disulfide in rat kidneys

H&E staining of renal tissues in control group showed overall integrity of glomerulus and convoluted tubules. Various morphological changes such as mild glomerular expansion, tubular dilation, vacuolization, tubular necrosis, and accumulation of cellular debris in the lumen of tubules were shown in glycerol-treated rat kidneys. PAS staining of renal tissues highlighted the loss of brush border in renal tubules of glycerol-treated rats as compared to control ones with intact brush border. DADS and pioglitazone attenuated glycerol-induced renal histological changes in rats. Prior administration of BADGE attenuated DADS-mediated correction of histological changes of rat kidneys in glycerol-intoxicated rats [Figures 3 and 4].
Figure 3

H&E staining of renal sections at ×400 magnification (A: control, B: Gly, C: Gly + DADS [50 mg/kg], D: Gly + DADS [100 mg/kg], E: Gly + Pio, and F: Gly + DADS + BADGE)

Figure 4

PAS staining of renal sections at ×400 magnification (A: control, B: Gly, C: Gly + DADS [50 mg/kg], D: Gly + DADS [100 mg/kg], E: Gly + Pio, and F: Gly + DADS + BADGE)

H&E staining of renal sections at ×400 magnification (A: control, B: Gly, C: Gly + DADS [50 mg/kg], D: Gly + DADS [100 mg/kg], E: Gly + Pio, and F: Gly + DADS + BADGE) PAS staining of renal sections at ×400 magnification (A: control, B: Gly, C: Gly + DADS [50 mg/kg], D: Gly + DADS [100 mg/kg], E: Gly + Pio, and F: Gly + DADS + BADGE)

DISCUSSION

Administration of glycerol markedly increased serum and urine biomarkers of kidney injury along with marked oxidative stress and histological changes in glycerol-intoxicated rats. Moreover, CK levels were elevated evidencing muscle injury. Our results revealed that administration of DADS is protective against glycerol-induced rhabdomyolysis in rats. DADS-mediated renoprotection was comparable to the pioglitazone in our model. In addition, prior administration of BADGE attenuated DADS-mediated protection in rats. It highlights the involvement of PPAR-γ in DADS-mediated renoprotection in rats. Garlic has been used as folk medicine as centuries and contains a wide range of biologically active molecules accounting for its medicinal properties. Garlic possesses sulfur containing constituents such as allicin, DADS, diallyl trisulfide and S-allyl cysteine, which are noted to contribute to its antioxidant properties and anti-aging action.[18] The protective effect of DADS has been shown in various animal models such as gentamicin-induced nephrotoxicity, acetaminophen-induced renal injury, acetaminophen-induced acute hepatotoxicity, and carbon tetrachloride-induced hepatic oxidative damage.[1011,1920] DADS has been reported to reduce the expression of iNOS, which inhibits activated NO production in stimulated macrophages.[21] Another study has suggested that the potent antioxidant activity and anti-apoptotic effects of DADS occur via the Nrf-2-antioxidant response element pathway.[22] Glycerol induces intense muscle damage which results in release of myoglobin from skeletal muscles. Myoglobin is one of the key components of rhabdomyolysis-induced renal damage and results in kidney damage through renal vasoconstriction, intra-luminal cast formation, and direct heme protein-induced cytotoxicity.[23] Myoglobin-induced lipid peroxidation leads to the formation of F2-isoprostanes, which further act as potent renal vasoconstrictors.[24] Myoglobin precipitates with Tamm-Horsfall protein in the convoluted tubules thereby forming heme casts, which leads to tubular obstruction.[2] In our study, H&E staining revealed intense tubular damage and cast formation in glycerol-intoxicated rat kidneys which was marked attenuated by DADS treatment. PAS staining revealed glycerol led loss of brush border which was corrected by DADS in rats. Free radicals play key role in the pathogenesis of glycerol-induced kidney damage. Glycerol-intoxication led release of myoglobin increases lipid peroxides and F2-isoprostanes, which further augment renal damage.[24] Mitochondria are the target for myoglobin and iron ions, which induce reactive oxygen species.[25] in our study, glycerol administration resulted in marked oxidative stress in renal tissues of rats shown by increase in lipid peroxides, augmented generation of superoxide anion, and decreased glutathione levels in rat kidneys. DADS treatment attenuated oxidative stress and protected the kidneys against oxidative stress. Our results are in accordance in previous findings, where DADS-mediated cyto-protection is attributed to its antioxidant activity.[710,1120] PPARs belong to the nuclear receptor super family and play a crucial role in regulating lipid metabolism. PPAR-γ agonists are particularly used to treat type 2 diabetes mellitus by restoring insulin sensitivity. Thiazolidinediones, such as pioglitazone and rosiglitazone, are selective activators of PPAR-γ and are widely used for treating diabetes. Anti-inflammatory property of PPAR-γ agonists is well documented as later inhibit production of tumor necrosis factor-α and other pro-inflammatory cytokines.[26] Pioglitazone has noted to attenuate renal damage in diabetic rats through antioxidant activity and reduction in pro-inflammatory cytokines such as nuclear factor kappa B and infiltration of macrophages in kidneys.[27] PPAR-γ mediates the activation of Nrf-2 signaling that plays a vital role in cyto-protection against oxidative stress as well as in suppression of inflammation.[28] In our study, pioglitazone effectively attenuated glycerol-induced oxidative stress and renal damage in rats. Interestingly, relation between DADS-mediated activity and PPAR-γ has been revealed. In 3L3-L1 cells, DADS treatment has been noted to increase the expression of PPAR-γ.[13] Recently, DADS administration has been reported to potentiate the anti-obesity effect of green tea by increasing PPAR-γ activity.[12] To the best of our knowledge, we are the first to report relevance of PPAR-γ in DADS-mediated protection against kidney injury. The major limitation of our study is that we did not quantify the levels of renal PPAR-γ in various groups. Moreover, the CK levels decreased with DADS treatment in rats. Therefore, further investigations are required to prove whether DADS-mediated renoprotection is due to attenuation of muscle injury or its direct renoprotective effect. Further studies are required to confirm renoprotective effect of DADS in acute as well as chronic models of kidney injury. On the basis of our findings, it is concluded that DADS attenuates glycerol-induced renal damage in rats. In addition, PPAR-γ finds its essential involvement in DADS-mediated renoprotection in rats.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  27 in total

1.  Heme protein-ischemic interactions at the vascular, intraluminal, and renal tubular cell levels: implications for therapy of myoglobin-induced renal injury.

Authors:  R A Zager
Journal:  Ren Fail       Date:  1992       Impact factor: 2.606

2.  Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.

Authors:  Mona K Tawfik
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-05       Impact factor: 3.507

3.  Protective effects of diallyl disulfide against acetaminophen-induced nephrotoxicity: A possible role of CYP2E1 and NF-κB.

Authors:  Je-Won Ko; Jin-Young Shin; Jeong-Won Kim; Sung-Hyeuk Park; Na-Rae Shin; In-Chul Lee; In-Sik Shin; Changjong Moon; Sung-Ho Kim; Sung-Hwan Kim; Jong-Choon Kim
Journal:  Food Chem Toxicol       Date:  2017-02-17       Impact factor: 6.023

Review 4.  Rhabdomyolysis and acute kidney injury.

Authors:  Xavier Bosch; Esteban Poch; Josep M Grau
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

5.  Estradiol attenuates ischemia reperfusion-induced acute kidney injury through PPAR-γ stimulated eNOS activation in rats.

Authors:  Amrit Pal Singh; Nirmal Singh; Devendra Pathak; Preet Mohinder Singh Bedi
Journal:  Mol Cell Biochem       Date:  2018-09-07       Impact factor: 3.396

Review 6.  Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.

Authors:  Ramya Kapadia; Jae-Hyuk Yi; Raghu Vemuganti
Journal:  Front Biosci       Date:  2008-01-01

Review 7.  Peroxisome proliferator-activated receptors and the control of inflammation.

Authors:  A Cabrero; J C Laguna; M Vázquez
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2002-09

8.  Diallyl disulfide ameliorates gentamicin-induced oxidative stress and nephropathy in rats.

Authors:  José Pedraza-Chaverrí; Ana E González-Orozco; Perla D Maldonado; Diana Barrera; Omar N Medina-Campos; Rogelio Hernández-Pando
Journal:  Eur J Pharmacol       Date:  2003-07-18       Impact factor: 4.432

9.  The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases.

Authors:  Sandeep Tyagi; Paras Gupta; Arminder Singh Saini; Chaitnya Kaushal; Saurabh Sharma
Journal:  J Adv Pharm Technol Res       Date:  2011-10

10.  Diallyl disulfide attenuates acetaminophen-induced renal injury in rats.

Authors:  Jin-Young Shin; Ji-Hee Han; Je-Won Ko; Sung-Hyeuk Park; Na-Rae Shin; Tae-Yang Jung; Hyun-A Kim; Sung-Hwan Kim; In-Sik Shin; Jong-Choon Kim
Journal:  Lab Anim Res       Date:  2016-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.